Isanys Lifecare, a digital healthcare company based in Oxfordshire, have developed a wireless monitoring system that can detect the early onset of sepsis in patients.
The Patient Status Engine (PSE) is a wearable “smart patch” that continuously collects a patients vital signs. The system then monitors the data and alerts clinicians to any changes in the patient's condition; changes that could indicate the early onset of sepsis that would have otherwise gone undetected.
In a recent report from the BBC News, patients' lives are still being put at risk due to delays giving them treatment for sepsis. Antibiotics should be administered within an hour if sepsis is suspected, however the report indicates approximately a quarter of patients are waiting longer. The UK Sepsis Trust estimates approximately 250,000 cases of sepsis every year in the UK and more than 50,000 deaths. Isansys hopes their device could significantly reduce these figures by identifying signs of sepsis at the very earliest onset.
Keith Errey, CEO of Isansys, said: “Being able to identify patients at the highest risk of deterioration is key for clinicians and nurses. Too often their workloads are overwhelming and they don’t have time to observe their patients closely at all times. Our technology does this for them and provides earlier indications of patient deterioration than can’t be achieved with manual monitoring alone. This is invaluable in the global fight against sepsis.
“Not only does the PSE provide early warning scores and alerts when a patient’s vital signs significantly change but it also allows the real-time monitoring of patients’ responses to treatment. This enables timely interventions which enhance the care and safety of patients.”
PSE has already been trialled in UK hospitals such as Birmingham Woman's and Children’s NHS Foundation Trust with favourable results. The company is also working with hospitals in Europe, India, Australia and the US to offer PSE as standard care for patient monitoring.
Northwell Health Group in New York is also carrying out a study into the use of PSE in labour as maternal fever is a major indicator of neonatal sepsis.